FindTrial
Sign In

Registration Study of Ultrafiltration in Heart Failure Patients in China (China-UF-HF)

Registration Study for Ultrafiltration in Heart Failure Patients in China (China-UF-HF)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000030696
Enrollment
Unknown
Registered
2020-03-10
Start date
2017-04-01
Completion date
Unknown
Last updated
2020-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure

Interventions

Case series:ultrafiltration

Sponsors

Fuwai Hospital Chinese Academy of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: Patients with acute heart failure treated with ultrafiltration

Exclusion criteria

Exclusion criteria: (1) the systolic blood pressure is less than 90mmHg and the peripheral circulation is bad. (2) contraindication of heparin anticoagulant; (3) severe mitral or aortic stenosis; (4) acute right ventricular myocardial infarction; (5) people who need dialysis or hemofiltration treatment; (6) systemic infection characterized by fever, systemic poisoning and leucocyte elevations.

Design outcomes

Primary

MeasureTime frame
Body weight;Dyspnea;urine volume;BNP;creatinine;JVP;IVC-CI;—

Countries

China

Contacts

Public ContactYuhui Zhang
YuhuiZhangjoy@163.com+86 15901314243

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 25, 2026